Selective Alterations in Ionotropic Glutamate Receptors in the Anterior Cingulate Cortex in Schizophrenia

Neuropsychopharmacology

Volumn 27, Issue 5, 2002, Pages 826-833

  Zavitsanou, Katerina ^a   Ward, Philip B ^a   Huang, Xu Feng ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

AMPA; Autoradiography; Cingulate cortex; Kainate receptors; NMDA; Schizophrenia

Indexed keywords

DIZOCILPINE; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; TRITIUM;

ADULT; AGE; AGED; ARTICLE; AUTORADIOGRAPHY; CADAVER; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; QUANTITATIVE ANALYSIS; RECEPTOR DENSITY; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CEREBRAL CORTEX; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0036850510     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00347-0     Document Type: Article

References (39)

1. Arvanov V.L., Wang R.Y. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharm Exp Therapeutics. 289:1999;1000-1006.
2. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev. 31:2000;251-269.
3. Breese C.R., Freedman R., Leonard S.S. Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res. 674:1995;82-90.
4. Deakin J.F., Simpson M.D. A two-process theory of schizophrenia. evidence from studies in post-mortem brain J Psychiatr Res. 31:1997;277-295.
5. Deakin J.F., Slater P., Simpson M.D., Gilchrist A.C., Skan W.J., Royston M.C., Reynolds G.P., Cross A.J. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem. 52:1989;1781-1786.
6. Ekonomou A., Angelatou F. Upregulation of NMDA receptors in hippocampus and cortex in the pentylenetetrazol-induced "kindling" model of epilepsy. Neurochem Res. 24:1999;1515-1522.
7. Giardino L., Bortolotti F., Orazzo C., Pozza M., Monteleone P., Calza L., Maj M. Effect of chronic clozapine administration on [3H]MK801-binding sites in the rat brain. a side-preference action in cortical areas Brain Res. 762:1997;216-218.
8. Grimwood S., Slater P., Deakin J.F., Hutson P.H. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport. 10:1999;461-465.
9. Healy D.J., Haroutunian V., Powchik P., Davidson M., Davis K.L., Watson S.J., Meador-Woodruff J.H. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology. 19:1998;278-286.
10. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 17:1994;31-108.
11. Ishimaru M., Kurumaji A., Toru M. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics. evidence for glutamate hypothesis Biol Psychiatry. 35:1994;84-95.
12. Jablensky A., Hugler H., von Cranach M., Kalinov K. Kraepelin revisited. a reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908 Psychol Med. 23:1993;843-858.
13. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148:1991;1301-1308. [see comments].
14. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine. from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology. 20:1999;201-225.
15. Keks N., Hill C., Opeskin K., Copolov D., Dean B. Psychiatric diagnosis after death. the problems of accurate diagnosis Dean B., Hyde T.M., Kleinman J. The Use of CNS Autopsy Tissue in Psychiatric Research. A Practical Guide:1999;19-37 Gordon & Breach Science Publishers, Sydney.
16. Kim J.S., Kornhuber H.H., Schmid-Burgk W., Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett. 20:1980;379-382.
17. Kornhuber J., Mack-Burkhardt F., Riederer P., Hebenstreit G.F., Reynolds G.P., Andrews H.B., Beckmann H. MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm. 77:1989;231-236. [3H].
18. Mai J.K., Assheuer J., Paxinos G. Atlas of the Human Brain. 1997;Academic Press, San Diego.
19. McCoy L., Cox C., Richfield E.K. Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse. 28:1998;195-207.
20. Meador-Woodruff J.H., Davis K.L., Haroutunian V. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology. 24:2001;545-552.
21. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev. 31:2000;288-294.
22. Monaghan D.T., Cotman C.W. The distribution of [3H]kainic acid binding sites in rat CNS as determined by autoradiography. Brain Res. 252:1982;91-100.
23. Monaghan D.T., Cotman C.W. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci. 5:1985;2909-2919.
24. Monaghan D.T., Yao D., Cotman C.W. Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography. Brain Res. 324:1984;160-164.
25. Nishikawa T., Takashima M., Toru M. Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci Lett. 40:1983;245-250.
26. Noga J.T., Hyde T.M., Bachus S.E., Herman M.M., Kleinman J.E. AMPA receptor binding in the dorsolateral prefrontal cortex of schizophrenics and controls. Schizophr Res. 48:2001;361-363.
27. Noga J.T., Hyde T.M., Herman M.M., Spurney C.F., Bigelow L.B., Weinberger D.R., Kleinman J.E. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse. 27:1997;168-176.
28. Paxinos G., Huang X.F., Toga A. The Monkey Brain in Stereotaxic Coordinates. 2000;Academic Press, San Diego.
29. Reynolds I.J., Miller R.J. Allosteric modulation of N-methyl-D-aspartate receptors. Adv Pharmacol. 21:1990;101-126.
30. Simpson M.D.C., Slater P., Deakin J.F.W. Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia. Biol Psychiatry. 44:1998;423-427.
31. Simpson M.D.C., Slater P., Royston M.C., Deakin J.F.W. Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Schizophrenia Res. 6:1992;41-48.
32. Spurney C.F., Baca S.M., Murray A.M., Jaskiw G.E., Kleinman J.E., Hyde T.M. Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats. Synapse. 34:1999;266-276.
33. Tamminga C.A., Vogel M., Gao X., Lahti A.C., Holcomb H.H. The limbic cortex in schizophrenia. focus on the anterior cingulate Brain Res Brain Res Rev. 31:2000;364-370.
34. Tarazi F.I., Florijn W.J., Creese I. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology (Berl). 128:1996;371-379.
35. Vogt B.A., Pandya D.N. Cingulate cortex of the rhesus monkey. II. Cortical afferents J Comp Neurol. 262:1987;271-289.
36. Vogt B.A., Rosene D.L., Pandya D.N. Thalamic and cortical afferents differentiate anterior from posterior cingulate cortex in the monkey. Science. 204:1979;205-207.
37. Zavitsanou K., Huang X.-F. Decreased [3H]spiperone binding in the anterior cingulate cortex in schizophrenia patients. an autoradiographic study Neuroscience. 109:2002;709-716.
38. Zavitsanou K., Mitsacos A., Giompres P., Kouvelas E.D. Changes in [3H]AMPA and [3H]kainate binding in rat caudate-putamen and nucleus accumbens after 6-hydroxydopamine lesions of the medial forebrain bundle. an autoradiographic study Brain Res. 731:1996;132-140.
39. Zilles K. Cortex. Paxinos G. The Human Nervous System. 1990;757-802 Academic Press, San Diego.